GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings
GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings
GoodRx Holdings Inc. (GDRX) shares surged nearly 10% Wednesday afternoon following the announcement of a new direct contracting agreement with Kroger Co. (NYSE:KR).
在宣布与克罗格公司签订新的直接合同协议后，GoodRx控股公司（GDRX）股价周三下午飙升了近10％。（纽约证券交易所代码：KR）。
What To Know: The agreement, spanning over 2,200 Kroger Family Pharmacy locations nationwide, aims to enhance prescription pricing accessibility and affordability for consumers.
须知：该协议涵盖全国2,200多个克罗格家庭药房，旨在提高消费者的处方定价可及性和可负担性。
GoodRx and Kroger said the companies reached a mutually beneficial agreement that enables them to deliver lower prices directly to patients. GoodRx noted that it had been focused on transforming how it delivers value to retail pharmacies in recent years.
GoodRx和克罗格表示，两家公司达成了一项互惠互利的协议，使他们能够直接向患者提供更低的价格。GoodRx指出，近年来，它一直专注于改变其为零售药房提供价值的方式。
"We are excited to renew our relationship with Kroger. Kroger has been a valuable participant in the GoodRx marketplace over the years and an innovator in healthcare, nutrition and wellness. We've leveraged our direct contracting model to reach an agreement that we believe supports Kroger's business goals and helps patients get the prescriptions they need at affordable prices," said Scott Wagner, interim CEO of GoodRx.
“我们很高兴恢复与克罗格的关系。多年来，克罗格一直是GoodRx市场的重要参与者，也是医疗保健、营养和保健领域的创新者。我们利用直接签约模式达成了一项协议，我们认为该协议支持克罗格的业务目标，并帮助患者以可承受的价格获得所需的处方。” GoodRx临时首席执行官斯科特·瓦格纳说。
As a result of the agreement, patients will be able to present a GoodRx coupon at Kroger Pharmacies to receive more savings on the expected patient price for most generics, beginning on June 1.
根据该协议，从6月1日开始，患者将能够在克罗格药房出示GoodRx优惠券，以便在大多数仿制药的预期患者价格上获得更多优惠。
GoodRx remains steadfast in its commitment to providing transparent and affordable prescription pricing. The direct-contracting agreement with Kroger promises nearly 50% more savings on most generics.
GoodRx仍然坚定不移地致力于提供透明且负担得起的处方价格。与克罗格的直接合同协议承诺在大多数仿制药上节省近50％。
GoodRX shares were up 9.43% at $7.29 at the time of writing, according to Benzinga Pro.
根据Benzinga Pro的数据，在撰写本文时，GoodRx股价上涨9.43％，至7.29美元。
译文内容由第三方软件翻译。